Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
about
Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technologyPharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica).Comparison between Transdermal Buprenorphine and Transdermal Fentanyl for Postoperative Pain Relief after Major Abdominal SurgeriesA novel approach in the detoxification of intravenous buprenorphine dependence.Update on prescription extended-release opioids and appropriate patient selection.High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometryBuprenorphine 5, 10 and 20 μg/h transdermal patch: a guide to its use in chronic non-malignant pain.Treatment of chronic pain in older people: evidence-based choice of strong-acting opioids.Assessment of extended-release opioid analgesics for the treatment of chronic pain.Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.Buprenorphine: revisiting the efficacy of transdermal delivery system.An evidence-based program to improve analgesic practice and pain outcomes in residential aged care facilities.Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.Use of strong opioids for chronic pain in osteoarthritis: an insight into the Latin American reality.Efficacy and Safety of Transdermal Buprenorphine versus Oral Tramadol/Acetaminophen in Patients with Persistent Postoperative Pain after Spinal Surgery.Effects of local and spinal administrations of mu-opioids on postoperative pain in aged versus adult mice.Comparative study of the efficacy of transdermal buprenorphine patches and prolonged-release tramadol tablets for postoperative pain control after spinal fusion surgery: a prospective, randomized controlled non-inferiority trial.Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM).Differences between Transdermal Fentanyl and Buprenorphine in the Elderly Hospice Patients
P2860
Q28080140-18D08522-3162-4FC4-BFD7-8225D9FB88EEQ34620060-97B29BD1-EB0E-4617-AC50-1A8498AEE1D1Q36476375-3DE3D82F-C584-41D1-A8AC-EC76F5FD99D4Q37035679-085B1C16-4173-418A-9AB7-C696B9488C6AQ37053718-D9664B1F-A09A-420A-B0E4-48E0EA4B54A4Q37606401-3E454D76-E219-499A-85FF-C3D3DE1A05FBQ37988549-8B5B0670-8520-4C9B-9977-42647D985685Q38024162-E192805E-006F-4D62-868A-3280EC5D7569Q38092855-DC00D388-AFFE-44D3-9C6A-49B541688D65Q38244523-640D7BAF-D344-456E-9588-5E198A1BD976Q38399076-9B2D4988-E144-4C26-AF7F-9FD8D693491EQ38495007-50FC1FA7-1A61-43BE-A038-1AE1AB5FD927Q39203712-540723C1-FCC4-4809-A925-DE2A563263C4Q39206999-280661C9-07B8-42E0-B7C0-A5F5468FC7DDQ43076011-67A51EF2-BB1D-4FE2-9D47-323A5F196DCBQ43374980-EC80D57C-B5D7-48B3-AEFA-B1A671F024B3Q47154586-2CB7E111-91C3-445F-83E6-CE586EE52B93Q50524056-75F07404-52F3-4129-9E36-E481695EAF7DQ54960408-2AAA8332-14B8-46DF-94BF-9B2CBE4E2831Q58565617-B1ED4458-DDDD-4F7F-9749-C2D2C2274A40
P2860
Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@en
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@nl
type
label
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@en
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@nl
prefLabel
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@en
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@nl
P2860
P1433
P1476
Buprenorphine 5, 10 and 20 μg/ ...... of chronic non-malignant pain.
@en
P2860
P304
P356
10.2165/11208250-000000000-00000
P577
2011-12-01T00:00:00Z
P6179
1000994014